Follow Us:
Blog
Dermalorian™ Podcast Series
June Episode of the Dermalorian™ Podcast Available from DEF!The latest episode of the Dermalorian™ Podcast, A Diversity of Diagnoses, is part one of a two-part discussion of significant dermatologic diagnoses that may impact patients with skin of color. Cutaneous...
Skin Cancer
Kristine Kucera, PA-C, MPAS, DHS Sunburns, Skin Aging and Skin Cancer: Surprising Attitudes Skin cancer is the most common type of cancer in the United States. Non-melanoma skin cancer (NMSC) is more common than melanoma, but melanoma causes the most skin...
Disseminated superficial actinic porokeratosis (DSAP)
Kristine Kucera, PA-C, MPAS, DHS Disseminated Superficial Actinic Porokeratosis Disseminated superficial actinic porokeratosis (DSAP) is an inherited disease of disordered keratinization. Risk factors include genetics, immunosuppression, and ultraviolet light...
Dermalorian™ Podcast Series
Dermatology Education Foundation Launches Dermalorian™ Podcast SeriesDEF has launched an informative monthly podcast just for NPs and PAs in dermatology. While DEF looks forward to DERM2023 and its recently announced Stranger Dx theme, the Dermalorian isn’t going...
SUN PROTECTION
Kristine Kucera, PA-C, MPAS, DHS Sun Protection Safety Update In the late 1970s, the promotion of sun protection was almost nonexistent, even though Swiss researcher Franz Greiter had developed the concept of SPF (sun protection factor). The first products...
iPLEDGE
Kristine Kucera, PA-C, MPAS, DHS FDA Panel Votes to Modify Isotretinoin iPLEDGE REMS The American Academy of Dermatology Association (AADA) in conjunction with the American Acne and Rosacea Society (AARS) and other stakeholders has been working with the U.S....
BIOSIMILARS
Kristine Kucera, PA-C, MPAS, DHS Preparing for the Launch of Biosimilars Biologic therapies have revolutionized the way that we treat autoimmune diseases in our daily practice. The term biologic is defined as an approved product composed of proteins, nucleic...
Final Update from AAD 2023
Hair Loss in Women with Skin of Color: Expert Tips from AAD 2023 It’s known that hair loss in women can be emotionally devastating and may detrimentally impact quality of life, but new research suggests that it can also be associated with having other common medical...
2nd Update from AAD 2023
Promising Data for Investigational Biologics for AD and HS Presented at AAD Annual Meeting 2023 Two investigational biologics show promise for the treatment of hidradenitis suppurativa (HS), while a third novel biologic is being explored in atopic dermatitis...
Update from AAD 2023
Aquavit Files NDAs for Neuromodulator for Hyperhidrosis, Shares Updates at AAD Annual Meeting Botulinum Toxins have shown to be effective treatment options for hyperhidrosis, specifically axillary and palmar hyperhidrosis, and new options may be forthcoming....